{"url_path":"/sec/mdln/8-k/2026-07-09/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-09","source_url":"https://www.sec.gov/Archives/edgar/data/2046386/0001104659-26-082249-index.html","accession_number":"0001104659-26-082249","cik":"0002046386","ticker":"MDLN","issuer_name":"Medline Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2046386/0001104659-26-082249-index.html","primary_entity_key":"0002046386","primary_entity_name":"Medline Inc."},"word_count":108,"has_tables":true,"body_markdown":"**Item 5.02. Departure of Directors or Certain\nOfficers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\nOn July 7, 2026, Stephen L. Miller, Chief\nOperating Officer of Medline Inc. (the “Company”), notified the Company that he would retire from his role, effective\nAugust 30, 2026, for health-related reasons. The Company is launching a search for his successor.\n\n \n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.\n\n \n\nDate: July 9, 2026\n\n \n\n \n**MEDLINE INC.**\n\n \n \n \n\n \nBy:\n*/s/\nAlex M. Liberman*\n\n \n \nName:\nAlex\nM. Liberman\n\n \n \nTitle:\nChief\nLegal Officer"}